Methotrexate for oral mucous membrane (cicatricial) pemphigoid: experience at an academic dermatology outpatient clinic

J Am Acad Dermatol. 2022 Dec;87(6):1431-1433. doi: 10.1016/j.jaad.2022.08.006. Epub 2022 Aug 7.

Authors

Matthew L Hrin¹, Josiah A Williams², Nathan L Bowers², Christine S Ahn², Lindsay C Strowd²

Affiliations

¹ Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina. Electronic address: matthewhrin@virginia.edu.
² Department of Dermatology, Wake Forest School of Medicine, Winston-Salem, North Carolina.

PMID: 35948167
DOI: 10.1016/j.jaad.2022.08.006

No abstract available

Keywords: cicatricial; methotrexate; mucous membrane pemphigoid; oral; pemphigoid; steroid-sparing; treatment.

MeSH terms

Ambulatory Care Facilities
Dermatology*
Humans
Methotrexate / therapeutic use
Mouth Mucosa
Mucous Membrane
Pemphigoid, Benign Mucous Membrane* / diagnosis
Pemphigoid, Benign Mucous Membrane* / drug therapy
Pemphigoid, Bullous*

Substances

Methotrexate